These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 3812152)

  • 21. Impact of dietary calcium and oxalate ratio on urinary stone formation in rats.
    Morozumi M; Ogawa Y
    Mol Urol; 2000; 4(4):313-20. PubMed ID: 11156697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Iatrogenic oxalic lithiasis caused by pyridoxilate].
    Wolf C; Maistre-Charransol G; Barthelemy C; Ottavioli JN; Thomas E; Thomas J
    Nephrologie; 1985; 6(5):225-7. PubMed ID: 4094636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Body size and 24-hour urine composition.
    Taylor EN; Curhan GC
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of citrate feeding on free radical induced changes in experimental urolithiasis.
    Selvam R; Bijikurien T
    Indian J Exp Biol; 1992 Aug; 30(8):705-10. PubMed ID: 1459650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prophylaxis of oxalate urolithiasis with alkaline citrates.
    Frang D; Berényi M; Szebeni R
    Ther Hung; 1990; 38(2):64-70. PubMed ID: 2377983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Combined administration of calcium and citrate reduces urinary oxalate excretion].
    Ito H
    Hinyokika Kiyo; 1991 Oct; 37(10):1107-10. PubMed ID: 1755399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction of the urinary risk factors of urolithiasis with magnesium and tartrate mixture: a new treatment.
    Hallson PC; Rose GA
    Br J Urol; 1988 May; 61(5):382-4. PubMed ID: 3395794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of citrate complexes in preventing urolithiasis.
    Ashby RA; Sleet RJ
    Clin Chim Acta; 1992 Sep; 210(3):157-65. PubMed ID: 1468138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Indicators of the risk of calcium oxalate urinary calculi: comparative study of the Parks' and Tiselius' indices, urinary citrate/calciuria ratio, and morning crystalluria].
    Robert M; Boularan AM; Guiter J; Monnier L
    Prog Urol; 1996 Apr; 6(2):264-8. PubMed ID: 8777421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of verapamil on urinary calcium and oxalate excretion in renal stone formers].
    Iguchi M; Ikegami M; Kiwamoto H; Umekawa T; Ishikawa Y; Kohri K; Kurita T
    Hinyokika Kiyo; 1993 May; 39(5):425-31. PubMed ID: 8322624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Influence of urinary citrate levels on spontaneous calcium oxalate dihydrate crystalluria].
    Hassani MA; Hennequin C; Lacour B; Daudon M
    Prog Urol; 2005 Sep; 15(4):650-5. PubMed ID: 16459680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Biochemical effects of potassium citrate in the treatment of calcium oxalate lithiasis].
    Conte Visús A; Ibarz Servio L; Arrabal Martín M; Ibarz Navarro JM; Ruiz Marcellán FJ
    Arch Esp Urol; 1994 Mar; 47(2):141-50. PubMed ID: 8002670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The preventive effect of sodium pentosan polysulfate against renal stone formation in hyperoxaluric rats.
    Nakatani T; Ishii K; Yoneda Y; Kamikawa S; Kanazawa T; Sugimoto T; Osswald H
    Urol Res; 2002 Oct; 30(5):329-35. PubMed ID: 12389123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-molecular-weight dextran sulfate prevents experimental urolithiasis in rats.
    Tostes V; Martinusso CA; Werneck CC; Mourão PA; Cardoso LR
    Clin Chim Acta; 2004 Mar; 341(1-2):147-55. PubMed ID: 14967171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen replacement increased the citrate and calcium excretion rates in postmenopausal women with recurrent urolithiasis.
    Dey J; Creighton A; Lindberg JS; Fuselier HA; Kok DJ; Cole FE; Hamm L
    J Urol; 2002 Jan; 167(1):169-71. PubMed ID: 11743298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Citrate (CG-120) therapy in urolithiasis. 2. Effect on urinary and serum biochemistry ].
    Ohkawa T; Ebisuno S; Morimoto S; Yasukawa S; Sonoda T; Koide T; Oka T; Aso Y; Higashihara E; Kitagawa R
    Hinyokika Kiyo; 1988 May; 34(5):918-31. PubMed ID: 3051946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of sex hormones on renal osteopontin expression and urinary constituents in experimental urolithiasis.
    Yagisawa T; Ito F; Osaka Y; Amano H; Kobayashi C; Toma H
    J Urol; 2001 Sep; 166(3):1078-82. PubMed ID: 11490302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of takusha and kagosou on calcium oxalate renal stones in rats].
    Yamaguchi S; Jihong L; Utsunomiya M; Yoshioka T; Okuyama A; Koide T; Sugiyama K
    Hinyokika Kiyo; 1995 Jun; 41(6):427-31. PubMed ID: 7645450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful treatment of hyperuricosuric calcium oxalate nephrolithiasis with potassium citrate.
    Pak CY; Peterson R
    Arch Intern Med; 1986 May; 146(5):863-7. PubMed ID: 3963975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of inhibitor deficiency in urolithiasis. II. Deficiency grade-adjusted and intermittent augmentation therapy for magnesium and citrate deficiency.
    Esen T; Akinci M; Tellaloğlu S; Koçak T
    Eur Urol; 1991; 19(3):244-8. PubMed ID: 1855531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.